Responses
Complementary medicine
Protocol
Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trial
Compose a Response to This Article
Other responses
No responses have been published for this article.